|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4030 EUR | +0.37% |
|
+4.56% | -5.31% |
Company Valuation: Thor Medical
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 737.7 | 1,859 | 1,598 | - | - |
| Change | - | 151.99% | -14.01% | - | - |
| Enterprise Value (EV) 1 | 737.7 | 1,678 | 1,781 | 1,775 | 1,804 |
| Change | - | 127.51% | 6.14% | -0.34% | 1.63% |
| P/E | -14.6x | -30.9x | -31.7x | -40.4x | -63.4x |
| PBR | - | 4.08x | 3.93x | 3.58x | 3.79x |
| PEG | - | 5.56x | 1.8x | 1.9x | 1.7x |
| Capitalization / Revenue | - | 2,216x | 32.6x | 9.51x | 8.69x |
| EV / Revenue | - | 2,000x | 36.4x | 10.6x | 9.81x |
| EV / EBITDA | - | -34.4x | -42.4x | -104x | 1,804x |
| EV / EBIT | - | -24.1x | -26.2x | -33.5x | -56.4x |
| EV / FCF | - | -13.9x | -9.95x | -37x | -361x |
| FCF Yield | - | -7.19% | -10% | -2.7% | -0.28% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.18 | -0.17 | -0.14 | -0.11 | -0.07 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | 0.839 | 49 | 168 | 184 |
| EBITDA 1 | - | -48.73 | -42 | -17 | 1 |
| EBIT 1 | - | -69.65 | -68 | -53 | -32 |
| Net income 1 | -42.21 | -58.01 | -49 | -40 | -24 |
| Net Debt 1 | - | -180.6 | 183 | 177 | 206 |
| Reference price 2 | 2.630 | 5.250 | 4.440 | 4.440 | 4.440 |
| Nbr of stocks (in thousands) | 280,492 | 354,077 | 360,002 | - | - |
| Announcement Date | 3/28/25 | 3/27/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.56x | 8.38x | 25.87x | 0.05% | 57.28B | |
| 20.68x | 6.37x | 13.94x | 1.54% | 54.99B | |
| -41.86x | 13.29x | -39.17x | -.--% | 23.18B | |
| -17.88x | 4.15x | -7.26x | -.--% | 22.59B | |
| 25.74x | 5.04x | 13.35x | -.--% | 20.46B | |
| 24.54x | 4.77x | 15.5x | -.--% | 17.56B | |
| -787.21x | 37.41x | -4211.77x | -.--% | 15.67B | |
| 43.58x | 17.61x | 45.34x | 0.08% | 14.46B | |
| 17.42x | 5.04x | 11.77x | -.--% | 13.92B | |
| Average | -75.71x | 11.34x | -459.16x | 0.19% | 26.68B | |
| Weighted average by Cap. | -36.72x | 9.70x | -264.23x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NANOV Stock
- 8NN Stock
- Valuation Thor Medical
Select your edition
All financial news and data tailored to specific country editions
